Kenwood Therapeutics, a division of Bradley Pharmaceuticals, Inc. announced the addition of Entsol Nasal Gel as a line extension to the Entsol family of products.

Bradley announced the introduction of Entsol Nasal Gel as an expansion of its Entsol Buffered Hypertonic Saline Nasal Wash line of products. Entsol Nasal Gel, a drug-free, hypertonic saline nasal gel with Aloe and Vitamin E, is gentle enough to use every day, as often as needed and is available in a convenient, take-anywhere, pocketsize tube for on-the-spot better breathing. A recent study has reported that a hypertonic nasal saline solution has been shown to reduce the severity of symptoms associated with sinusitis.

Bradley Pharmaceuticals president and CEO, Daniel Glassman, stated, “Bradley is pleased to provide Entsol Nasal Gel as an addition to the Entsol Buffered Hypertonic Saline Nasal Wash line of products."

Bradley Pharmaceuticals, Inc. is a specialty pharmaceutical company marketing prescription niche therapies to highly targeted physician audiences in the United States and in 34 international markets. Dermatology brands are delivered by the Doak Dermatologics subsidiary and the Kenwood Therapeutics division provides gastroenterology, nutritional and respiratory therapies.